The study was designed to investigate the changes in the CSF concentrations of M, M3G and M6G in cancer patients previously treated with systemic opioids after initiation of pain relief with small doses of intracerebroventricular (lCV) morphine (0.2 mg to 5 mg daily).
( < 10 nM). Very satisfactory pain relief was achieved with very low doses of ICV morphine (0.2-5 mg daily) and gastrointestinal side-effects were markedly reduced.
Conclusion: Cancer patients with pain partially responsive to, but tolerant of, the analgesic effects of large doses of systemic morphine (up to 4 g daily) achieve very satisfactory pain relief and do not develop tolerance to the very low doses of ICV morphine (0.2-5 mg daily) despite the very high morphine concentrations achieved by the ICV route of administration. For this reason it is highly unlikely that morphine itself plays a major role in the development of tolerance. (SCIDUA) Deaths occurring within 24 hours of anaesthesia in NSW from 1984 to 1990 were reviewed by SCIDUA.
There were 1500 deaths before full recovery from anaesthesia in approximately 3.5 million surgical procedures. Three-quarters of the cases were abdominal, cardiothoracic and vascular cases, and 70010 were emergency cases. Males outnumbered females 1.75:1. Trauma in the 20-29 age group and vascular and cardiothoracic surgery in the 50-79 age group were mainly responsible for the gender difference.
In nearly two-thirds of patients, deaths were inevitable (60.7%) or fortuitous (3.9%). In one-third of cases, the surgical procedure (22.1 %), anaesthesia (5.8%) or both (5.3%) was a cause or a factor in the fatal outcome. In 188 of 397 of the deaths related to surgical factors and 11 of 161 deaths related to anaesthesia factors, no better alternative procedure was possible and the procedures were correctly performed. In 93% of cases where death resulted from or was contributed to by anaesthesia, errors of techniques or management occurred. In these cases there was an average of 2.2 errors per case. Inadequate management of patients both preoperatively and postoperatively each contributed to death occurring in one-third of the patients. Choice of anaesthetic agent or technique contributing to death also occurred in over one-third of cases and overdose of anaesthetic agent or drug occurred in more than one-quarter.
The mortality rate in which anaesthesia is a factor is approximately one in 20,000 operations, which is one-quarter the rate in the 1960s. Aims: Intrathecal administration of midazolam has been shown by Goodchild I to exhibit somatic nociceptive qualities. This study was designed to determine the efficacy of intrathecal midazolam 2 mg as an adjunct to spinal blockade with local anaesthesia.
Methods: Following local Ethical Committee
approval, written, informed consent was obtained from twenty-four patients scheduled for elective total hip replacement. They were randomly allocated to receive intrathecal midazolam 2 mg in 3 ml 5070 dextrose solution or placebo. These preparations were administered immediately after the preoperative spinal blockade injection of 0.5070 heavy bupivacaine.
Once the spinal injections had been administered, standardised general anaesthesia was performed. Supplementary postoperative analgesia was provided by morphine via patient-controlled analgesia. Patients recorded their visual analogue score (VAS) on a 10 cm line. Investigators recorded emetic and sedation scores, completed a short-form Magill pain questionnaire (SFMPQ) 2 and dermatomally mapped pinprick and temperature sensation. Pruritus, urinary catheterisation and headache occurrence were also noted.
Results:
One patient was withdrawn from the midazolam group. Both treatment groups did not differ in mean age, weight, height, duration of operation or intraoperative blood loss. There was no significant difference between the groups in mean morphine consumption and VAS scores during the first 24 hours. Further, there was no difference in SFMPQ replies, dermatomal mapping, emesis or sedation scoring during the first 72 hours of pruritus, headache and urinary catheterisation rate at 72 hours.
Conclusion:
There is no clinical benefit in combining midazolam with local anaesthetic agents for spinal anaesthesia.
References I. Goodchild CS, Noble J. Hr J Clin Pharm 1987; 23:279-285. 2. Melzac R. Pain 1987; 30:191-197 Spinal cord monitoring during scoliosis surgery has become routine, and ideally should alert a surgeon to otherwise undetectable dysfunction of spinal cord pathways before adverse changes become irreversible. For this, the motor evoked potential (MEP), in addition to the somatosensory evoked potential (SSEP), must be recorded. The MEP may be recorded from a limb muscle as the compound muscle potential (CMAP), or as a spinal cord volley in response to transcranial electrical or magnetic stimulation using epidurally placed recording electrodes.
We have systematically compared the effect of the volatile anaesthetic agents and nitrous oxide upon the MEP responses to magnetic and electrical stimulation and the CMAP in 140 patients (87 females and 53 males aged two to 57 years).
With electrical stimulation, when supramaximal stimulus levels were used, the epidural MEP remained quite stable at surgical levels of anaesthesia for prolonged periods and could be recorded continuously. The CMAP was very difficult to obtain under anaesthesia and required an extremely light level, mainly based around small doses of intravenous agents, avoiding muscle relaxants and inhalational agents. The magnetically induced epidural MEP, even at maximum stimulus levels, could be abolished completely by volatile anaesthetic agents and could not be continuously recorded. August. 1993 sidestream and mainstream devices were compared sequentially. Capnograph waveforms were recorded (HP deskjet 500 and Spacelabs 90449). Four-point calibrations of both systems were performed in the laboratory using standard concentrations of C02. Both systems were again calibrated using air and 4.9070 C02 prior to each recording session. Data on weight and type of ventilation were also collected.
Conclusion
To obtain C02 samples with the sidestream device we inserted a 22-gauge cannula through a 21-gauge needle hole 12 cm from the tip of the endotracheal tube. Sidestream flow rate was 170 mllmin.
The mainstream cuvette was inserted at the endotracheal tube connector and measurements were obtained immediately, to avoid any trend upwards in the EtC02 caused by the 2.0 ml extra deadspace.
Results: Paired data points (n=22) were analysed using regression analysis. Post dural puncture headache has a high incidence (Cesarini found 15070 incidence with 25-gauge cutting needle) in young females and is a major drawback to using spinal anaesthesia for obstetrics. The purpose of this study was to determine if the incidence of post dural puncture headache is decreased by the use of a Sprotte pencil point needle.
Method' 88 consenting obstetric patients undergoing LSCS, trial of forceps or removal of retained placenta were randomised to receive a spinal anaesthetic with either 24-gauge Sprotte needle or 25-gauge cutting needle. Treatment of both groups was otherwise identical and according to protocol. Patients were followed up independently on days 1 and 2 and at 1 and 2 weeks for neurological complications and post dural puncture headache.
Results: 8/43 patients on whom the 25-gauge cutting needle was used experienced a post dural puncture headache, of which five required blood patching. 0/45 patients on whom the 24-gauge Sprotte needle was used experienced a post dural puncture headache. Chisquared analysis gave a P value of ~0.05.
Conclusion: We concluded that these results were highly significant for 24-gauge Sprotte needle decreasing the incidence of post dural puncture headache, without any evidence of other early or late complications. Aim: To assess the efficacy of ondansetron 4 mg IV for the prophylaxis of nausea and vomiting after gynaecological laparoscopic surgery.
Methodology: 140 ASA 1-11 nonpregnant Asian females aged 18 to menopause scheduled for gynaecological laparoscopic surgery were enrolled in this double-blind randomised study. Patients received either ondansetron 4 mg (n=68) or placebo (n=72) IV before anaesthesia with thiopentone 4-5 mg/kg, fentanyl 2{tg/kg, atracurium 0.5 mg/kg, 70070 N20 and 0.5-1070 isoflurane. Atropine and neostigmine were given at the end of surgery. Postoperatively, episodes of retching and vomiting were recorded in the recovery room and for 24 hours in the ward. Nausea was graded by the patients on a 0-10 point verbal numeric scale and recorded over the same period. Statistics: Mann Whitney or Fisher exact test as appropriate.
Results: Demographic data were similar between groups. On arrival in the recovery room, 6070 of the ondansetron group and 18070 of the placebo group had nausea (P< 0.05). For the first hour, 14070 of the ondansetron group and 36070 of the placebo had retching or vomiting (P < 0.05). Over the next 24 hours, only 24070 of the ondansetron group had retching or vomiting, compared with 60070 of the placebo group (P<0.05). A complete antiemetic response (no nausea, retching or vomiting) overall was achieved in 56070 of the ondansetron group and 25070 of the placebo group
(P<O.OI).
Conclusion: Ondansetron 4 mg IV given before induction of anaesthesia was effective in reducing postoperative nausea and vomiting. Patients undergoing major upper abdominal surgery develop a restrictive lung pattern which may be associated with hypoxia. The purpose of this study was to compare the degree of hypoxia seen with systemic opiates compared with a low-dose epidural infusion of bupivacaine and fentanyl.
Patients (n = 17) were included if they required major upper abdominal surgery and postoperative intravenous nutrition. Allocation to the two groups was not random. Analgesia in the opiate group (Group 1, n=8) consisted of morphine or pethidine PCA or infusion. Four of these patients entered this group because of failed epidurals. The epidural group (Group 2, n=9) received an infusion of bupivacaine (0.15070) and fentanyl (15 mcg.ml-I ) via a low thoracic epidural. Age, sex, bodymass index, smoking history and procedure duration were recorded for each patient. Arterial blood gases (PaOz) were collected one day preoperatively and two days postoperatively, with the patients breathing room air in the supine position.
In group 1 the Pa02 fell by 30 mmHg (P<O.OOI, SD 13 mmHg) to a mean of 61 mmHg on day 2. In group 2 it fell by 20 mmHg (P<O.OOI, SD 10 mmHg) to a mean of 69 mmHg on day 2. However, the difference in the fall between the two groups was not significant (P=O.1). The difference was also not significant when linear regression analysis was used to correct for the other variables (P=O.4) .
We conclude from this population group that hypoxia frequently occurs after major upper abdominal surgery and it is not affected by the type of analgesia used (systemic opioids vs epidurals).
Aims: The aims of this study were to determine how much information patients want about postoperative analgesia, how they want this information to be presented to them and how much risk they are prepared to accept in order to obtain good pain relief. The attitudes of medical and nursing staff involved in managing postoperative pain were also sought.
Methods: With Ethics Committee approval, 74 elective surgical patients were asked about risks and side-effects from pain-relieving therapies. A similar questionnaire was sent to 50 registered nurses and 52 medical staff (surgeons and anaesthetists). KruskalWallis tests were used to compare respondent groups where the response was odrered categories.
Results: Almost half (46070) of patients were unaware that there might be risks or significant side-effects associated with the treatment of postoperative pain. 91070 of patients wanted information about these sideeffects and 62070 of doctors and 88070 of nurses reported they gave such information. 68070 of patients thought this information should be obtained by discussion with the surgeon, although 79070 of doctors thought it should be provided by the anaesthetist. All nurses thought the information should be given by nurses. 56070 of patients wanted such information only about the pain therapy chosen for them by the medical staff. Patients were willing to accept a significantly greater risk of serious side-effects, such as major nerve damage or paralysis, to achieve excellent pain relief than were doctors (P<O.OOI) 
or nurses (P<0.02).
Conclusion: Patients want information on sideeffects from analgesic therapy and, whilst generalisations can be made, there was sufficient heterogeneity in responses to suggest the need for an individualised approach for each patient when obtaining informed consent for a particular technique of pain management. It appears that patients look to the surgeon for relevant information even though the anaesthetist is generally responsible for initiating postoperative pain therapy. Preoxygenation before induction of anaesthesia reduces the risk of hypoxia during rapid-sequence induction or difficult intubation.
PREOXYGENATION: CAN PATIENT FACTORS
The aim of this study was to use the measurement of end tidal oxygen concentration (Et02) as the indicator of alveolar denitrogenation (Et02 > 90070). A number of patient parameters were recorded to determine if they could be used to predict the time required for preoxygenation. The parameters were: age, sex, weight, height, smoking status, level of sedation, HR, BP and ASA score.
After Ethics Committee approval and patient consent, 200 patients were studied before induction of anaesthesia. A standard method of preoxygenation was used for all patients using a circle absorber system with It is not generally appreciated that an ampoule of atracurium is presented as a racemic mixture of 10 distinct isomers which can be separated by Normal Phase HPLC into 3 geometric groups; Cis-Cis(C-C), Cis-Trans(C-T) and Trans-Trans(T-T). These are present in the proportions 60:35:5 per cent respectively. Initial pharmacokinetic studies did not differentiate these isomer groups, leading to an apparent non-linearity in in-vitro degradation studies. Using atracurium synthesised from "optically pure" precursors to give R-R(d-d), R-S/S-R(d-lIl-d) and S-S(l-l) isomer subgroups, we have determined their rate of degradation in human plasma at 37 QC and pH7.4. For "racemic" atracurium, the tYz is 23 mins, if the initial 10 minute period is ignored. For the isomer groups we have found the R-R group to have a tYz of 2l.8 min; the S-S group C-C 22.5 min, C-T 4.75 min, T-T 3.21 min; the R-S/S-R group demonstrate biphasic elimination of the C-T groups with a tYz of 22.l min for C-C. Variation in tYz is not observed in O.l M phosphate or after the addition of octanol to the plasma. These findings support stereospecific enzyme mediated degradation of some of the atracurium isomers. Allowing for an onset half life of approximately two minutes, it is probable that the potency of these isomers has been underestimated. Method: The animals were anaesthetised with ketamine and halothane, paralysed with pancuronium, ventilated and physiologically monitored throughout the procedure. Regional and systemic blood flow were measured using microspheres labelled with four radioactive lanthanides. The microspheres were injected into the left atrium immediately prior to cross-clamping (T 1, Sm 153), ten minutes after clamping (T2, Nd 147), sixty minutes after clamping (T3, La 140) and thirty minutes after release of the clamp (T 4, Yb I49 ). At these four times the heart rate systemic arterial, pulmonary artery and pulmonary wedge pressures, cardiac output (thermodilution) and temperature were also recorded. Simultaneously, arterial blood samples were taken to determine blood gases, acid-base status, sodium clearance and creatinine clearance.
Results: On the basis of the continuous monitoring, fluid and cardiovascular parameters were maintained as close as possible to the preclamp levels. The results were assessed by analysis of variance. During infrarenal cross-clamping of the aorta there was a rise in the systemic arterial pressure and pH, and a reduction in blood flow to the sigmoid colon. There were no significant changes in the cardiac output, pulmonary artery pressure or blood flow to the myocardium, kidneys, liver, stomach or spinal cord.
Conclusion:
It was therefore concluded that fluctuations in blood flow to vital organs can be minimised during infrarenal aortic cross-clamping by appropriate fluid therapy.
This study was supported by a Research Grant from the Australian and New Zealand College of Anaesthetists.
EPIDURAL BLOCK AND OUTCOME AFTER MAJOR SURGERY J R. A. Rigg, St John of God Hospital, Subiaco, Western Australia Recent critical studies of the effect of epidural block (EB) on outcome provide conflicting conclusions. I tested the hypothesis that this conflict is due primarily to inadequate study design. I I conducted a systematic review of the literature from 1974 to identify research papers that met five criteria: I. Only "High Risk" patients were studied; 2. All patients had "major" surgery; 3. A comprehensive set of major morbidity variables were used to assess outcome; 4. A randomised control design was used; and, 5. The intervention studied was ER Four recent papers, identified as the most important, were subjected to detailed methodological analysis. 2 Results and Conclusion: There were considerable differences in methods of patient selection. Among studies, no patient groups were comparable demographically or in type, extent and duration of surgery. Site of EB varied from lumbar to low thoracic. EB was maintained for varying durations using different analgesia regimens. Defined outcome measures varied markedly, both in the methods of measurement and in the rates observed. Statistical power was discussed in two papers, but prior determination of sample size was not discussed in any paper. Where authors reported power estimates, the calculations were wrong. My power calculations, using the authors' data, 501110 morbidity decrease and =0.05, for both single variables or cumulative morbidity within a single organ system, ranged from 11 to 50%. I conclude that conflicting results and conclusions in these papers reflect inadequate planning, design and execution of research, as indicated by these sub-optimal power estimates. I
REVERSAL OF NEUROMUSCULAR BLOCKADE BY EDROPHONIUM G. H. Beemer, P H. Goonetilleke, A. R. Bjorksten, Department of Anaesthesia, The Royal Melbourne Hospital, Melbourne, Victoria
There has been renewed interest in the use of edrophonium to reverse competitive neuromuscular blockade; however, many of its important properties as a reversal agent have yet to be determined. The aim of this study was to determine the efficacy of edrophonium to antagonise varying levels of steadystate neuromuscular blockade. Steady-state blockade was chosen to exclude the confounding effects of spontaneous recovery of the neuromuscular blocking agent. Atracurium was infused to maintain a constant level of block, which was monitored by train-of-four stimulation (TOF) with a Grass FT-1O force transducer attached to the thumb. The block was antagonised by small incremental doses of edrophonium, while the infusion of atracurium continued. A further incremental dose was administered after the peak effect of the preceding dose. A cumulative dose-response curve was constructed for each patient from a logit-log plot. The probability of being able to antagonise the block was determined by probit analysis. Twenty-seven patients were studied. In 14 patients the block was antagonised to a mF ratio of 2: 70070 byedrophonium, with a block of 26-77070 depression of the first twitch height (TOF count 3-4) at reversal. In 13 patients the block was incompletely antagonised, with a block of 56-93% twitch depression (TOF count 1-4). The probability of reversing a block to a TOF ratio 2: 70% was 90% when the block was 53% depression of the first twitch height, 50% probability at 67% depression and 10% probability at 82% depression. The dose of edrophonium required to completely antagonise the block in patients with the block 2: 50% depression of first twitch at reversal (n = 10) was 0.35 mg/kg (95 % confidence interval 0.1-0.6 mg/kg). It is concluded that edrophonium can only reliably antagonise low levels of neuromuscular block and that the TOF count should be 3-4 before it is administered. The maximum effective dose of edrophonium for reversal is of the order of 
PHARMACOKINETICS OF VECURONIUM DURING INFUSION A. R. Bjorksten, G. H. Beemer, Department of Anaesthesia, The Royal Melbourne Hospital, Melbourne, Victoria
The pharmacokinetic data for vecuronium derived from traditional single-bolus studies is highly variable, as illustrated by mean clearance estimates ranging from 3.2 to 5.3 mllmin/kg. Its predictive value in designing infusion regimens, which is one of the primary uses for such data, is limited. The aim of this study was to estimate the pharmacokinetics of vecuronium during continuous infusion. Fifteen patients were studied under propofol anaesthesia. A loading dose of vecuronium was administered, followed by a constantrate infusion. Frequent arterial blood samples were taken for later determination of the vecuronium plasma concentration by an HPLC assay. Patients were studied for two to four hours. Plasma concentration data were analysed using the population pharmacokinetic program NONMEM. Vecuronium plasma concentration data were best described by a three-compartment which similarly satisfy the computational need but do not offer an explanation of the observations. A model is proposed which fulfils both objectives. The twitch evoked force of contraction of a muscle is approximately proportional to the number of contracting fibres. If the neuromuscular junctions of a muscle are distributed in a Gaussian (normal) manner in respect of the concentration of drug necessary to block them, or in respect of the logarithm of the concentration, then the effect-concentration relation will be represented by the area under the normal (or log-normal) curve (Equation 1). X=concentration, X=ECso, a=SD.
This hypothesis was tested using concentration effect data from eight patients during recovery from atracurium block. The goodness of fit for the three models was similar. The ECsos derived from the three models (Hill, normal and log-normal distribution) were 301, 307 (P < 0.05) and 301 mcg.l-1 • The two Gaussian models offer a rational explanation of the concentration-effect relations of relaxants. The normal and log-normal models could not be distinguished by goodness of fit, but logical considerations favour the log-normal model. Background: This study was undertaken to confirm a previous report that patients having neurological changes with carotid artery clamping were at greater risk of developing permanent postoperative neurological complications following carotid endarterectomy.
NEUROLOGICAL CHANGES DURING CAROTID ENDARTERECTOMY UNDER
Methods: Superficial and deep cervical plexus blocks were performed in 389 patients having carotid endarterectomy. The regional blocks were usually carried out with 25-40 ml of 1.5070 lignocaine with 1:200,000 adrenaline. The patients were premedicated and sedated to a level which allowed awake neurological assessment. Intraoperative neurological changes were recorded and all patients were followed up postoperatively by an independent anaesthesiologist to record postoperative neurological outcome.
Results: Trial carotid artery cross-clamping resulted in 24070 of patients having neurological changes which usually respond to declamping and shunt insertion. Postoperative permanent neurological complications occurred in 2.6070 of patients but were more common in patients who had neurological changes associated with carotid artery cross-clamping (6.6070 compared to 1.1 070, P < 0.01). Thrombosis of the carotid artery was the most common finding in patients who underwent re-exploration after developing postoperative neurological changes.
Conclusion: This study confirms that patients undergoing carotid endarterectomy under cervical plexus block who have intraoperative neurological changes have a six-fold increase in the chance of developing a postoperative stroke. This high-risk group may benefit from anti thrombotic therapies to improve their outcome.
The Ohmeda PAC Universal Drawover Vaporiser maximises drawover performance, but at the expense of plenum. The PAC is actively temperaturecompensated, unlike its passively "thermostabilised" competitor, the Penlon Oxford Miniature Vaporiser (OM V). The OMV is intended for drawover and plenum mode. I Aim: To compare the PAC and OMV, in laboratory simulations of field conditions.
Methods: Test runs, 10 minutes long, used isoflurane, PAC/OMV set full on. Calibration curves at run-start and run-end were obtained for each combination of temperature (-1, 8, 22, 34, 55°C ), carrier gas volume/minute (2, 4, 6 litres), and mode of flow. Temperature-chamber air was the drawover gas, moved by a Penlon Oxford ventilator. The plenum gas, oxygen, allowed continuously to ambient pressure.
Results: Drawover, from -1 to 45°C, the PAC output increased only x 2 (vs OMV x 5), and was altered little by either volume/minute (vs OMV x 1.5) or time (OMV also). Above 34°C, the PAC (not OMV) leaked vapour (0.1-0.2070) at its OFF setting. Above 45°C, PAC outputs were uncontrollable, but not the OMV's.
Easy OMV modifications (at < 8°C, two OMVs in series; at > 30°C a specific external bypass) reduced its -1 to 55 °C output variation to x 2, the same as the PAC's. 2 Plenum, the PAC's flow-and temperature-dependent outputs compared very unfavourably with the OMV's, which were similar to drawover.
Conclusions: The drawover performance of each vaporiser was very good over a wide temperature range, within which the PAC's was somewhat more predictable. The OMV was the more versatile device. Method: The ETT-tip to carina distance was measured in 50 patients during surgery using a fibreoptic technique. Measurements were made after moving the head from the neutral position to 30 ° flexion, 30 ° extension, 70 ° rotation to right, 70 ° rotation to left and 20° Trendelenburg tilt. All measurements were made with the cuff inflated.
ALTERATIONS IN ENDOTRACHEAL
Results: The range of movement, mean and SD for each of the five positions are shown: (+ = increase and -= decrease in ETT-tip to carina distance (mm». Conclusion: Significant mean inward movement of the ETT-tip (i.e. shortening of the ETT-tip to carina distance) occurred with neck flexion and significant outward movement occurred with neck extension. This finding is in keeping with an earlier study. J However, the magnitude of the movement following flexion or extension was much less than in that study and the direction of movement in individual cases was inconsistent. Other postural changes did not produce any significant trends in the direction of tip movement, although in individual cases quite large movements were observed. Toxic shock syndrome is a clinically defined entity observed following the use of tampons, surgical packs or prostheses. Cardiovascular collapse follows activation of a specific set of T-lymphocytes by the superantigen or Toxic Shock Syndrome Toxin (TSST-l) which binds exclusively to the V (32 chain of the T-cell receptor. Binding leads to rapid cytokine release and clinical illness. Animal models of the syndrome suggests lifelong immune damage may follow such activation. A group of 12 patients who survived the syndrome were investigated longitudinally using an antibody we developed to the V(32 chain. We observed a small increase in the proportion of v(32 subset in the peripheral T-lymphocyte population during the initial two weeks following hospital admission. In the same period we identified few V (32 positive lymphocytes Anaesthesia and Intensive Care, Vol. 21, No. 4, August, 1993 expressing CD4 (helper/inducer lymphocytes) and none expressing CD45RA (naive lymphocytes). Some two weeks after admission, a small proportion of CD4 + ve lymphocytes were detectable. By the sixth week the blood samples matched those from normal controls. Proliferation assays demonstrated that patients' lymphocytes responded similarly to activation by TSST-l, recall antigen and a V(32 antibody in all phases of the illness. Superantigen in vivo therefore leads to acute distortion of the V (32 T-lymphocyte subset. There were no long-lasting immunological sequelae providing the patient survives the acute phase of the illness. It is advocated for use as a diagnostic and therapeutic tool in intestinal ischaemia. We aimed to study the relationship of pHi above (gastric pHi) and below (sigmoid pHi) an infrarenal cross clamp to gut blood flow measured by radiolabelled microspheres (RLM).
Method: Nine juvenile pigs were anaesthetised with ketamine and halothane, paralysed with pancuronium and ventilated throughout the procedure. Arterial and pulmonary artery pressure, thermodilution cardiac output, ECG, EtC02 and temperature were all monitored. Gastric and sigmoid tonometers were placed and position confirmed at laparotomy. Gastric and sigmoid pHi, gastric lumen pH and haemodynamic parameters were measured on five occasions: basal (B), immediately pre-clamp (C), 30 minutes post clamp (C + 30), 60 minutes post clamp (C + 60) and 30 minutes after clamp release (R + 30). At times C, C + 30, C + 60 and 6 + 30 blood flow to stomach and sigmoid colon was measured using RLM.
Results: Analysis of variance demonstrated no significant changes in haemodynamic parameters (mean arterial pressure, cardiac output, mean pulmonary artery pressure and pulmonary capillary wedge pressure). There were no significant changes in gastric pHi and blood flow. The sigmoid pHi fell significantly with cross clamp (P 0.008) as did sigmoid blood flow (P 0.02), whereas sigmoid blood flow was restored to ~ basal levels, sigmoid pHi remained low at R + 30. Based mainly on data from obstetric analgesia and caesarean sections, the use of fentanyl-bupivacaine has gained widespread currency for postsurgical analgesia. On review, the evidence for this practice is not altogether convincing. This double-blind, withinpatient, controlled cross-over study was designed to compare fentanyl (50 mcg) in 10 ml saline with similar doses in 0.25 and 0.125070 bupivacaine with 10 ml 0.5070 bupivacaine, which, based on previous studies offered the best analgesia. The study was performed on 24 patients who had undergone major abdominal surgery under general anaesthesia. Each possible sequence of the four treatments was administered to one patient. The results are summarised in the There was no significant difference in linear analog pain scale, 0-3 pain score or duration of relief. Hypotension was more frequent following 0.5070 bupivacaine than with the other three treatments and other adverse effects were not significantly different among the treatments. This study does not demonstrate any advantage in the use of bupivacaine-fentanyl mixtures over fentanyl alone for analgesia following major abdominal surgery. Method: After institutional ethics committee approval 16 patients were randomised to receive either epidural fentanyl (5 mcg/ml) and l/ 400,000 adrenaline at 10 ml/hr or bolus morphine « 5 mg each 6 to 12 hrs). Analgesia was titrated to patient requirements by Acute Pain Service personnel. An observer blind to the analgesic technique recorded YAS (rest and cough), ventilatory-C02 response using Read's technique, resting ventilation, and endtidal C02 for three days postoperatively at 8 a.m., 4 p.m., and 9 p.m. Respiratory parameters including daily lung volumes were compared with preoperative values or predischarge values in cases of lung resection.
RESPIRATORY EFFECTS OF EPIDURAL
Results statistical methods (e.g. Student's t-test, ANOYA). However, doubt about whether YAPs adequately meet the assumptions underlying these methods has led many investigators to prefer non parametric analyses. This study investigated the validity of applying parametric tests to YAPs. Concerns regarding validity of the tests fall into two categories: measurement problems and statistical problems. Measurement problems arise from uncertainty in the relationship between the YAPs and the true underlying pain intensity. These uncertainties are important in the interpretation of YAPs and results of tests applied to them, but do not lead to bias in results of parametric statistical tests. The major statistical problem is the nonnormal shape of YAPs distributions. Consequences of this were investigated by simulation experiments, using YAPs distributions from patients with cancerrelated pain and patients with chronic non-cancer pain. For total sample sizes of at least 10, Student's 2-sample t-test on YAPs performed well at a nominal significance level of 0.05 (Table 1) . Performance was poorer at a significance level of 0.01, when sample sizes were grossly unequal, and when a I-tailed test was used. Derived pain measures performed better than the raw YAPs. The paired t-test pe formed very poorly for YAPs, even with a sample size of 30. It is concluded that under some circumstances YAPs may be analysed using parametric techniques, but that in some cases, e.g. for paired data, nonparametric tests should be used. 
